PACB icon

Pacific Biosciences
PACB

Overview Fund Activity

141 hedge funds and large institutions have $432M invested in Pacific Biosciences in 2016 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 70 increasing their positions, 27 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
141
Holders Change
+12
Holders Change %
+9.3%
% of All Funds
3.77%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
29
Increased
70
Reduced
27
Closed
15
Calls
$4.08M
Puts
$5.66M
Net Calls
-$1.58M
Net Calls Change
-$876K

Top Buyers

1
Lord, Abbett & Co
1
Lord, Abbett & Co
New Jersey
$43.4M
2
RCM
2
Raging Capital Management
New Jersey
$12.3M
3
BM
3
Bridger Management
New York
$36.5M
4
Capital World Investors
4
Capital World Investors
California
$6.89M
5
Wells Fargo
5
Wells Fargo
California
$6.53M

Top Sellers

1
CCM
1
Consonance Capital Management
New York
$7.84M
2
EAM
2
EverPoint Asset Management
Connecticut
$0
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$0
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$0
5
GTC
5
Ghost Tree Capital
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Northwestern Mutual Wealth Management
151
Northwestern Mutual Wealth Management
Wisconsin
– -$133K -15,601 Closed
Balyasny Asset Management
152
Balyasny Asset Management
Illinois
– -$94K -11,100 Closed
RCP
153
Rothschild Capital Partners
New York
– -$91K -10,750 Closed
QT
154
Quantbot Technologies
New York
– -$52K -6,211 Closed
CSS
155
Cubist Systematic Strategies
Connecticut
– -$38K -4,453 Closed
PCM
156
Prelude Capital Management
New York
– -$8K -990 Closed
3 4 5 6
7